BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 19639185)

  • 1. Fisetin inhibits liver cancer growth in a mouse model: Relation to dopamine receptor.
    Liu XF; Long HJ; Miao XY; Liu GL; Yao HL
    Oncol Rep; 2017 Jul; 38(1):53-62. PubMed ID: 28560391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line.
    Li A; Song J; Lai Q; Liu B; Wang H; Xu Y; Feng X; Sun X; Du Z
    Int J Exp Pathol; 2016 Dec; 97(6):412-421. PubMed ID: 27995666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells.
    Poplineau M; Doliwa C; Schnekenburger M; Antonicelli F; Diederich M; Trussardi-Régnier A; Dufer J
    Cell Prolif; 2013 Apr; 46(2):127-36. PubMed ID: 23510467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications.
    Jakubikova J; Adamia S; Kost-Alimova M; Klippel S; Cervi D; Daley JF; Cholujova D; Kong SY; Leiba M; Blotta S; Ooi M; Delmore J; Laubach J; Richardson PG; Sedlak J; Anderson KC; Mitsiades CS
    Blood; 2011 Apr; 117(17):4409-19. PubMed ID: 21321360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells.
    Reed K; Hembruff SL; Laberge ML; Villeneuve DJ; Côté GB; Parissenti AM
    Epigenetics; 2008 Sep; 3(5):270-80. PubMed ID: 19001875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1.
    Hawley TS; Riz I; Yang W; Wakabayashi Y; Depalma L; Chang YT; Peng W; Zhu J; Hawley RG
    Am J Hematol; 2013 Apr; 88(4):265-72. PubMed ID: 23475625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells.
    Hui RC; Francis RE; Guest SK; Costa JR; Gomes AR; Myatt SS; Brosens JJ; Lam EW
    Mol Cancer Ther; 2008 Mar; 7(3):670-8. PubMed ID: 18347152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells.
    El-Khoury V; Gomez D; Liautaud-Roger F; Trussardi-Régnier A; Dufer J
    Cytometry A; 2004 Dec; 62(2):109-17. PubMed ID: 15517561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.
    Besse A; Stolze SC; Rasche L; Weinhold N; Morgan GJ; Kraus M; Bader J; Overkleeft HS; Besse L; Driessen C
    Leukemia; 2018 Feb; 32(2):391-401. PubMed ID: 28676669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide alters nuclear architecture without ABCB1 gene modulation in drug-resistant myeloma cells.
    Trussardi-Regnier A; Lavenus S; Gorisse MC; Dufer J
    Int J Oncol; 2009 Sep; 35(3):641-7. PubMed ID: 19639185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of multidrug resistance protein MDR1/ABCB1 in carfilzomib-resistant multiple myeloma differentially affects efficacy of anti-myeloma drugs.
    Byrgazov K; Kraus M; Besse A; Slipicevic A; Lehmann F; Driessen C; Besse L
    Leuk Res; 2021 Feb; 101():106499. PubMed ID: 33422770
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular pathways: regulation and therapeutic implications of multidrug resistance.
    Chen KG; Sikic BI
    Clin Cancer Res; 2012 Apr; 18(7):1863-9. PubMed ID: 22344233
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.